Upgrade to SI Premium - Free Trial

Xylem reports eight percent increase in organic revenue and orders, and strong double-digit growth in 2nd quarter 2018 earnings

July 31, 2018 6:55 AM

RYE BROOK, N.Y.--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported second quarter 2018 net income of $115 million, or $0.64 per share. Excluding the impact of restructuring, realignment and other special items, the Company delivered adjusted net income of $131 million or $0.73 per share in the quarter, a 24-percent increase over the prior year period. Second quarter revenue was $1.3 billion, up 13 percent including the impact of foreign exchange and acquisitions. Revenue for the quarter increased eight percent on an organic basis, driven by double-digit growth in utilities and continued strength in the industrial and commercial end markets across nearly all major geographies. Orders increased eight percent organically in the quarter. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin improved by 70 basis points year-over-year to 19.3 percent driven by volume leverage and savings from productivity initiatives. Reported operating margin in the quarter was 13 percent and adjusted operating margin increased 70 basis points year-over-year to 13.8 percent, including a 20-basis-point negative impact due to purchase accounting amortization.

Patrick Decker, President and Chief Executive Officer of Xylem, said, “Our second quarter results were very strong as our team continued to successfully execute on our strategy to generate consistent, profitable growth. Once again, we delivered high single-digit organic growth in revenue and orders globally, reflecting solid growth in each of the major geographic markets in which we operate. We are capturing share in the utilities end market where strong orders and backlog growth reflect continued momentum. As we indicated previously, we began implementing price increases earlier this year and I’m pleased with the traction we’ve gained in the marketplace. Our ability to successfully realize meaningful pricing impact, while continuing to execute our productivity initiatives, has and will continue to help us mitigate higher input costs from inflationary pressures and tariffs. Our strong operational performance in the first half of the year and continued momentum underpins our confidence in our updated expectations for the full year.”

Updated Full-year 2018 Outlook

Xylem now forecasts full-year 2018 revenue of approximately $5.2 billion, up more than 10 percent versus the prior year, including growth from previously announced acquisitions. On an organic basis, Xylem now anticipates revenue growth in the range of six to seven percent.

The Company has narrowed the range of its full-year 2018 earnings expectations. Reflected in this expectation is $0.04 of operational improvement driven by stronger operational execution and price realization offset by the impact of a strengthening dollar and divestiture of a non-core business. Full-year 2018 adjusted operating margin is now expected to be in the range of 13.9 to 14.2 percent, resulting in adjusted earnings per share of $2.85 to $2.95. This represents an increase of 19 to 23 percent from Xylem’s 2017 adjusted results. The Company’s adjusted earnings outlook excludes projected integration, restructuring and realignment costs, which now are expected to be approximately $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Second Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

Supplemental information on Xylem’s second quarter 2018 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s more than 16,500 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York with 2017 revenue of $4.7 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future – including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results – are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements. Factors that could cause results to differ materially from those anticipated include: economic, political and other risks associated with our international operations, including military actions, economic sanctions or trade barriers and embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission. Forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

Three Months Six Months
For the period ended June 30, 2018 2017 2018 2017
Revenue $ 1,317 $ 1,164 $ 2,534 $ 2,235
Cost of revenue 798 707 1,555 1,366
Gross profit 519 457 979 869
Selling, general and administrative expenses 293 270 589 542
Research and development expenses 50 44 91 86
Restructuring and asset impairment charges, net 5 6 15 18
Operating income 171 137 284 223
Interest expense 21 21 42 41
Other non-operating income (expense), net 2 5 5 4
(Loss) gain from sale of business (2 ) (2 ) 5
Income before taxes 150 121 245 191
Income tax expense 35 21 51 35
Net income 115 100 194 156
Less: Net income attributable to non-controlling interests 1 1
Net income attributable to Xylem $ 115 $ 99 $ 194 $ 155
Earnings per share:
Basic $ 0.64 $ 0.55 $ 1.08 $ 0.87
Diluted $ 0.64 $ 0.55 $ 1.07 $ 0.86
Weighted average number of shares:
Basic 179.8 179.6 179.8 179.6
Diluted 181.0 180.6 181.2 180.6
Dividends declared per share $ 0.2100 $ 0.1800 $ 0.4200 $ 0.3600
XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

June 30, 2018 December 31,2017
ASSETS
Current assets:
Cash and cash equivalents $ 321 $ 414
Receivables, less allowances for discounts and doubtful accounts of $31 and $35 in 2018 and 2017, respectively 1,019 956
Inventories 598 524
Prepaid and other current assets 168 177
Total current assets 2,106 2,071
Property, plant and equipment, net 643 643
Goodwill 2,996 2,768
Other intangible assets, net 1,269 1,168
Other non-current assets 218 210
Total assets $ 7,232 $ 6,860
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 580 $ 549
Accrued and other current liabilities 536 551
Short-term borrowings and current maturities of long-term debt 361
Total current liabilities 1,477 1,100
Long-term debt 2,179 2,200
Accrued postretirement benefits 426 442
Deferred income tax liabilities 288 252
Other non-current accrued liabilities 333 347
Total liabilities 4,703 4,341
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 192.8 shares and 191.9 shares in 2018 and 2017, respectively 2 2
Capital in excess of par value 1,932 1,912
Retained earnings 1,359 1,227
Treasury stock – at cost 13.2 shares and 12.4 shares in 2018 and 2017, respectively (486 ) (428 )
Accumulated other comprehensive loss (294 ) (210 )
Total stockholders’ equity 2,513 2,503
Non-controlling interests 16 16
Total equity 2,529 2,519
Total liabilities and stockholders’ equity $ 7,232 $ 6,860
XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

For the six months ended June 30, 2018 2017
Operating Activities
Net income $ 194 $ 156
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 58 55
Amortization 74 61
Share-based compensation 16 11
Restructuring and asset impairment charges 15 18
Loss (gain) from sale of business

2

(5 )
Other, net

(7

)

4
Payments for restructuring (12 ) (17 )
Changes in assets and liabilities (net of acquisitions):
Changes in receivables (68 ) (70 )
Changes in inventories (87 ) (13 )
Changes in accounts payable 54 (19 )
Other, net

(38

) (30 )
Net Cash – Operating activities 201 151
Investing Activities
Capital expenditures (111 ) (77 )
Acquisition of business, net of cash acquired (430 ) (6 )
Proceeds from sale of business 11
Other, net 4 3
Net Cash – Investing activities (537 ) (69 )
Financing Activities
Short-term debt issued, net 437 33
Short-term debt repaid (54 ) (65 )
Repurchase of common stock (58 ) (25 )
Proceeds from exercise of employee stock options 4 7
Dividends paid (76 ) (65 )
Other, net (1 )
Net Cash – Financing activities 252 (115 )
Effect of exchange rate changes on cash (9 ) 13
Net change in cash and cash equivalents (93 ) (20 )
Cash and cash equivalents at beginning of year 414 308
Cash and cash equivalents at end of period $ 321 $ 288
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest $ 46 $ 46
Income taxes (net of refunds received) $ 51 $ 47
Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses and special charges.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, adjusted net income and earnings per share, adjusted to exclude restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable. For Sensus historical adjustments, see Sensus Historical - Adjusted Operating Income table.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Sensus Acquisition Related Costs" defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.

“Special charges" defined as costs incurred by the Company, such as non-cash impairment charges, acquisition and integration related costs not related to Sensus and other special non-operating items.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Change % Change

Acquisitions /

Change % Change
Orders Orders 2018 v. 2017 2018 v. 2017

Divestitures

FX Impact Adj. 2018 v. 2017 Adj. 2018 v. 2017
2018 2017

Six Months Ended June 30

Xylem Inc. 2,698 2,349 349 15% (42) (86) 221 9% 11%
Water Infrastructure 1,134 988 146 15% - (42) 104 11% 11%
Applied Water 785 729 56 8% 10 (23) 43 6% 5%
Measurement & Control Solutions 779 632 147 23% (52) (21) 74 12% 20%

Quarter Ended June 30

Xylem Inc. 1,378 1,212 166 14% (34) (30) 102 8% 11%
Water Infrastructure 580 521 59 11% - (14) 45 9% 9%
Applied Water 401 375 26 7% 4 (9) 21 6% 5%
Measurement & Control Solutions & Analytics 397 316 81 26% (38) (7) 36 11% 23%

Quarter Ended March 31

Xylem Inc. 1,320 1,137 183 16% (8) (56) 119 10% 11%
Water Infrastructure 554 467 87 19% - (28) 59 13% 13%
Applied Water 384 354 30 8% 6 (14) 22 6% 5%
Measurement & Control Solutions 382 316 66 21% (14) (14) 38 12% 16%
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Change % Change

Acquisitions /

Change % Change
Revenue Revenue 2018 v. 2017 2018 v. 2017

Divestitures

FX Impact Adj. 2018 v. 2017 Adj. 2018 v. 2017
2018 2017

Six Months Ended June 30

Xylem Inc. 2,534 2,235 299 13% (41) (83) 175 8% 10%
Water Infrastructure 1,026 901 125 14% - (38) 87 10% 10%
Applied Water 754 694 60 9% 8 (22) 46 7% 5%
Measurement & Control Solutions 754 640 114 18% (49) (23) 42 7% 14%

Quarter Ended June 30

Xylem Inc. 1,317 1,164 153 13% (26) (29) 98 8% 11%
Water Infrastructure 546 482 64 13% - (13) 51 11% 11%
Applied Water 388 361 27 7% 3 (8) 22 6% 5%
Measurement & Control Solutions 383 321 62 19% (29) (8) 25 8% 17%

Quarter Ended March 31

Xylem Inc. 1,217 1,071 146 14% (15) (54) 77 7% 9%
Water Infrastructure 480 419 61 15% - (25) 36 9% 9%
Applied Water 366 333 33 10% 5 (14) 24 7% 6%
Measurement & Control Solutions 371 319 52 16% (20) (15) 17 5% 12%
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
Q1 Q2 YTD

2018

2017

2018

2017

2018

2017

Total Revenue
• Total Xylem 1,217 1,071 1,317 1,164 2,534 2,235
• Water Infrastructure 480 419 546 482

1,026 901
• Applied Water 366 333 388 361

754 694
• Measurement & Control Solutions 371 319 383 321 754 640
Operating Income
• Total Xylem 113 86 171 137 284 223
• Water Infrastructure 49 41 92 74

141 115
• Applied Water 50 36 61 48

111 84
• Measurement & Control Solutions 33 25 31 29 64 54
• Total Segments 132 102 184 151 316 253
Operating Margin
• Total Xylem 9.3% 8.0% 13.0% 11.8% 11.2% 10.0%
• Water Infrastructure 10.2% 9.8% 16.8% 15.4% 13.7% 12.8%
• Applied Water 13.7% 10.8% 15.7% 13.3% 14.7% 12.1%
• Measurement & Control Solutions 8.9% 7.8% 8.1% 9.0% 8.5% 8.4%
• Total Segments 10.8% 9.5% 14.0% 13.0% 12.5% 11.3%
Sensus Acquisition Related Costs
• Total Xylem - 10 - 4 - 14
• Water Infrastructure - - - - - -
• Applied Water - - - - - -
• Measurement & Control Solutions - 6 - 3 - 9
• Total Segments - 6 - 3 - 9
Special Charges
• Total Xylem 6 5 1 - 7 5
• Water Infrastructure - - - - -
• Applied Water - 5 - - 5
• Measurement & Control Solutions 2 - 1 - 3 -
• Total Segments 2 5 1 - 3 5
Restructuring & Realignment Costs
• Total Xylem 16 11 10 12 26 23
• Water Infrastructure 5 4 5 5 10 9
• Applied Water 3 4 2 5 5 9
• Measurement & Control Solutions 8 3 3 2 11 5
• Total Segments 16 11 10 12 26 23
Adjusted Operating Income
• Total Xylem 135 112 182 153 317 265
• Water Infrastructure 54 45 97 79

151 124
• Applied Water 53 45 63 53

116 98
• Measurement & Control Solutions 43 34 35 34

78 68
• Total Segments 150 124 195 166 345 290
Adjusted Operating Margin
• Total Xylem 11.1% 10.5% 13.8% 13.1% 12.5% 11.9%
• Water Infrastructure 11.3% 10.7% 17.8% 16.4% 14.7% 13.8%
• Applied Water 14.5% 13.5% 16.2% 14.7% 15.4% 14.1%
• Measurement & Control Solutions 11.6% 10.7% 9.1% 10.6% 10.3% 10.6%
• Total Segments 12.3% 11.6% 14.8% 14.3% 13.6% 13.0%
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q2 2018 Q2 2017

As Reported

Adjustments

Adjusted

As Reported

Adjustments

Adjusted

Total Revenue 1,317 1,317 1,164 1,164
Operating Income 171 11 a 182 137 16 a 153
Operating Margin 13.0% 13.8% 11.8% 13.1%
Interest Expense (21) (21) (21) (21)
Other Non-Operating Income (Expense) 2 2 5 5
(Loss)/Gain from sale of business (2) 2 - - -
Income before Taxes 150 13 163 121 16 137
Provision for Income Taxes (35) 3 b (32) (21) (9) b (30)
Income attributable to minority interest - (1) (1)
Net Income attributable to Xylem 115 16 131 99 7 106
Diluted Shares 181.0 181.0 180.6 180.6
Diluted EPS $ 0.64 $ 0.09 $ 0.73 $ 0.55 $ 0.04 $ 0.59
Year-over-year currency translation impact on current year diluted EPS $ 0.03 $ - $ 0.03
Diluted EPS at Constant Currency $ 0.61 $ 0.09 $ 0.70
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
Q2 YTD 2018 Q2 YTD 2017

As Reported

Adjustments

Adjusted

As Reported

Adjustments

Adjusted

Total Revenue 2,534 2,534 2,235 2,235
Operating Income 284 33 a 317 223 42 a 265
Operating Margin 11.2% 12.5% 10.0% 11.9%
Interest Expense (42) (42) (41) (41)
Other Non-Operating Income (Expense) 5 5 4 4

(Loss)/Gain from sale of business

(2) 2 - 5 (5) -
Income before Taxes 245 35 280 191 37 228
Provision for Income Taxes (51) (5) b (56) (35) (15) b (50)
Income attributable to minority interest - - (1) (1)
Net Income attributable to Xylem 194 30 224 155 22 177
Diluted Shares 181.2 181.2 180.6 180.6
Diluted EPS $ 1.07 $ 0.17 $ 1.24 $ 0.86 $ 0.12 $ 0.98
Year-over-year currency translation impact on current year diluted EPS $ 0.09 $ - $ 0.09
Diluted EPS at Constant Currency $ 0.98 $ 0.17 $ 1.15
a Second quarter: Restructuring & realignment costs of $10 million and $12 million in 2018 and 2017, respectively; special charges of $1 million of acquisition related costs in 2018 and $4 million of Sensus acquisition related costs in 2017.
First half: Restructuring & realignment costs of $26 million and $23 million in 2018 and 2017, respectively; 2018 special charges of $7 million and 2017 Sensus acquisition related costs of $19 million.
b Second quarter: Net tax impact on restructuring & realignment costs of $3 million and $5 million in 2018 and 2017, respectively; net tax impact on 2017 Sensus acquisition related costs of $1 million and tax-related special items of $6 million of benefit and $3 million of expense in 2018 and 2017, respectively.
First half: Net tax impact on restructuring & realignment costs of $7 million in both 2018 and 2017, respectively; net tax impact on 2018 special charges of $1 million; net tax impact on 2017 Sensus acquisition related costs of $7 million in 2017; net tax impact of $2 million on the gain from sale of business in 2017 and tax-related special items of $3 million of benefit and $3 million of expense in 2018 and 2017, respectively.
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
Q1 Q2 Six Months Ended
2018 2017 2018 2017 2018 2017
Net Cash - Operating Activities $ 63 $ 52 $ 138 $ 99 $ 201 $ 151
Capital Expenditures (61) (43) (50) (34) (111) (77)
Free Cash Flow $ 2 $ 9 $ 88 $ 65 $ 90 $ 74
Cash paid for Sensus acquisition related costs (1) (17) - (5) (1) (22)
Free Cash Flow, excluding Sensus Acquisition Related Costs $ 3 $ 26 $ 88 $ 70 $ 91 $ 96
Net Income 79 56 115 100 194 156
Gain/(Loss) from sale of businesses - 5 (2) - (2) 5
Special Charges - non-cash impairment and early debt extinguishment - (5) - - - (5)
Sensus acquisition related costs - (10) - (4) - (14)

Net Income, excluding gain on sale of businesses, non-cash impairment charges and Sensus Acquisition Related Costs

$ 79 $ 66 $ 117 $ 104 $ 196 $ 170
Free Cash Flow Conversion 4% 39% 75% 67% 46% 56%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
($ Millions)
2018
Q1 Q2 Q3 Q4 Total
Net Income 79 115 194
Income Tax Expense 16 35 51
Interest Expense (Income), net 20 20 40
Depreciation 29 29 58
Amortization 38 36 74
EBITDA 182 235 - - 417
Share-based Compensation 9 7 16
Restructuring & Realignment 16 9 25
Loss from sale of business - 2 2
Sensus Acquisition Related Costs - - -
Special Charges 6 1 7
Adjusted EBITDA 213 254 - - 467
Revenue 1,217 1,317 2,534
Adjusted EBITDA Margin 17.5% 19.3% 18.4%
2017
Q1 Q2 Q3 Q4 Total
Net Income 56 100 104 70 330
Income Tax Expense 14 21 27 74 136
Interest Expense (Income), net 20 20 20 19 79
Depreciation 28 27 28 26 109
Amortization 31 30 30 34 125
EBITDA 149 198 209 223 779
Share-based Compensation 6 5 5 5 21
Restructuring & Realignment 11 12 9 9 41
(Gain)/Loss from sale of business (5) - 1 14 10
Sensus Acquisition Related Costs 7 2 3 2 14
Special Charges 5 - 3 5 13
Adjusted EBITDA 173 217 230 258 878
Revenue 1,071 1,164 1,195 1,277 4,707
Adjusted EBITDA Margin 16.2% 18.6% 19.2% 20.2% 18.7%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Water Infrastructure
($ Millions)
2018
Q1 Q2 Q3 Q4 Total

Pre-Tax Income

47 90 137
Interest Expense (Income), net - (1) (1)
Depreciation 12 11 23
Amortization 5 5 10
EBITDA 64 105 - - 169
Share-based Compensation 1 - 1
Restructuring & Realignment 5 5 10
Adjusted EBITDA 70 110 - - 180
Revenue 480 546 1,026
Adjusted EBITDA Margin 14.6% 20.1% 17.5%
2017
Q1 Q2 Q3 Q4 Total
Pre-Tax Income 39 73 90 105 307
Interest Expense (Income), net - - (1) (1) (2)
Depreciation 11 11 12 11 45
Amortization 5 4 5 5 19
EBITDA 55 88 106 120 369
Share-based Compensation 1 - - 1 2
Restructuring & Realignment 4 5 3 4 16
Adjusted EBITDA 60 93 109 125 387
Revenue 419 482 520 583 2,004
Adjusted EBITDA Margin 14.3% 19.3% 21.0% 21.4% 19.3%
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Applied Water
($ Millions)
2018
Q1 Q2 Q3 Q4 Total
Pre-Tax Income 50 61 111
Interest, net - - -
Depreciation 5 5 10
Amortization - 1 1
EBITDA 55 67 - - 122
Share-based Compensation 1 1 2
Restructuring & Realignment 3 2 5
Adjusted EBITDA 59 70 - - 129
Revenue 366 388 754
Adjusted EBITDA Margin 16.1% 18.0% 17.1%
2017
Q1 Q2 Q3 Q4 Total
Pre-Tax Income 40 49 49 62 200
Interest, net - - - - -
Depreciation 5 5 5 5 20
Amortization 1 1 1 - 3
EBITDA 46 55 55 67 223
Share-based Compensation - 1 1 - 2
Restructuring & Realignment 4 5 5 3 17
Gain from sale of business (5) - 1 (2) (6)
Special Charges 5 - - - 5
Adjusted EBITDA 50 61 62 68 241
Revenue 333 361 354 373 1,421
Adjusted EBITDA Margin 15.0% 16.9% 17.5% 18.2% 17.0%
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Measurement & Control Solutions
($ Millions)
2018
Q1 Q2 Q3 Q4 Total
Pre-Tax Income 33 28 61
Interest Expense (Income), net - - -
Depreciation 8 9 17
Amortization 29 27 56
EBITDA 70 64 - - 134
Share-based Compensation 1 1 2
Restructuring & Realignment 8 3 11
Loss from sale of business

-

2

2

Special Charges 2 1 3
Adjusted EBITDA 81 71 - -

152

Revenue 371 383 754
Adjusted EBITDA Margin 21.8% 18.5%

20.2%

2017
Q1 Q2 Q3 Q4 Total
Pre-Tax Income 24 30 26 11 91
Interest Expense (Income), net - - - (1) (1)
Depreciation 8 8 7 7 30
Amortization 23 22 22 25 92
EBITDA 55 60 55 42 212
Share-based Compensation - 1 - 1 2
Restructuring & Realignment 3 2 1 2 8
Loss from sale of business - - - 16 16
Sensus Acquisition Related Costs 3 1 2 1 7
Special Charges - - - 2 2
Adjusted EBITDA 61 64 58 64 247
Revenue 319 321 321 321 1,282
Adjusted EBITDA Margin 19.1% 19.9% 18.1% 19.9% 19.3%
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.

Xylem Inc.

Media

Kelly McAndrew, +1 914-323-5969

[email protected]

or

Investors

Matt Latino, +1 914-323-5821

[email protected]

Source: Xylem Inc.

Categories

Press Releases

Next Articles